AlphaYou read
Insider Cluster
Smart-money signal on MEDP this 14d.
Smart-money signal on MEDP this 14d.
Conviction is weak; save it and wait for stronger confirmation.
Saved May 29, 2026. Day 13 of 30D; +4.1% vs S&P so far.
- Smart money6.0/40
- Fundamentals8.0/35
- Technicals1.0/15
- Macro3.3/10
Price
Stock chart
Snapshot
Quick facts
- Market cap
- $13.08B
- P/E ratio
- 28.82
- Forward P/E
- 27.25
- Beta
- 1.18
- 52-week range
- $294.07 - $628.92
- Dividend yield
- --
- Volume
- 4.87M
- Sector
- HEALTHCARE
Analysts
What do analysts expect?
Current
$464.41
Target
$442.83
Saved calls
Recent AlphaYou calls for this stock
- LONGMay 29Insider Cluster
Smart-money signal on MEDP this 14d.
Public call·Results pending - LONGMay 28Insider Cluster
Smart-money signal on MEDP this 14d.
Public call·Results pending
Smart money
What big buyers and insiders are doing
congressional trade
Rep. Hon. David J. Taylor bought MEDP ($1,001-$15,000)
congressional trade
Rep. Hon. David J. Taylor bought MEDP ($1,001-$15,000)
filing 13f fund flow
Renaissance Technologies LLC holds $261.7M (13F 2025-12-31)
filing 13f fund flow
Two Sigma Investments LP holds $84.8M (13F 2026-03-31)
filing 13f fund flow
Citadel Advisors LLC holds $33.6M (13F 2025-12-31)
filing nport p fund flow
Janus Detroit Street Trust (active ETFs) holds $17.3M (NPORT-P 2026-01-31)
Top trader activity
PendingReal trader activity will show here once the feed is ready.
BTC Astro risk regime
PendingA broad risk read. Used only as context, not as the main stock reason.
Who helped?
Sources tied to past calls on this stock
Source types
- SEC EDGAR 13F
Source family
D7
173
+1.16%
59.5% hit
D15
116
+0.68%
53.4% hit
D30
pending
- house-clerk-ptr-pdf
Source family
D7
26
+0.93%
53.8% hit
D15
16
+4.01%
75.0% hit
D30
pending
Funds, insiders, and filers
- TWO SIGMA INVESTMENTS, LP
FORM 13F FILER
D7
150
+1.44%
62.0% hit
D15
100
+0.81%
54.0% hit
D30
pending
- Hon. David J. Taylor
CONGRESS
D7
5
+1.23%
60.0% hit
D15
pending
D30
pending
Did it work?
How past calls did
No results yet for this stock.
Results appear 7, 15, and 30 days after a call.
Each row shows what happened after the call. Green means it beat the comparison; red means it lagged.
Source links
Can you check the original source?
Fundamentals
Is the business strong?
Valuation
- P/E28.82
- Forward P/E27.25
- P/S4.88
- P/B21.87
Quality
- Profit margin17.2%
- Operating margin20.0%
- ROE77.2%
- ROA17.5%
Growth
- Revenue YoY--
- Earnings YoY--
- Beta1.18
- Dividend yield--
Technicals
Chart health
Trailing returns
- 5d+1.11%
- 20d-0.61%
- 60d+0.53%
Trend vs moving averages
- vs SMA50+0.14%
- vs SMA200+0.41%
52w range position
Based on daily price data. Options flow and order-book data are not in this chart panel yet.
Macro
Market backdrop
- +15.7
macro regime shift
VIX 15.7 (low volatility) as of 2026-05-28
- +0.5
macro regime shift
10y-2y spread 46bps (flattish) as of 2026-05-28
- +102.5
macro regime shift
Industrial Production 102.5 (mild expansion) as of 2026-04-01
- +1.0
macro regime shift
Initial claims 215,000 vs 26w mean (ratio 1.01, neutral)
- +4.0
macro regime shift
CPI YoY 3.95% (hot vs Fed target)
Earnings
Did earnings help or hurt?
No earnings history yet for this stock.
Past earnings will show here when they are ready.
Bull vs bear
What could help or hurt?
Bullish view
- Rep. Hon. David J. Taylor bought MEDP ($1,001-$15,000)
- Rep. Hon. David J. Taylor bought MEDP ($1,001-$15,000)
- Renaissance Technologies LLC holds $261.7M (13F 2025-12-31)
- Two Sigma Investments LP holds $84.8M (13F 2026-03-31)
Bearish view
No reasons on this side yet.
Reasons come from smart money, fundamentals, technicals, and macro. Counts show how many reasons sit on each side.
Scorecard
Past call results
vs SPY
S&P 500
Typical edge
+6.37%
Avg edge
+6.37%
Hit rate
100.0%
Mean return
+3.87%
vs QQQ
Nasdaq-100
Typical edge
+8.37%
Avg edge
+8.37%
Hit rate
100.0%
Mean return
+3.87%
Results are grouped by stock, direction, and day so the same call is not counted twice.